HCA Healthcare Inc (NYSE:HCA) Receives $147.29 Consensus Target Price from Analysts

Shares of HCA Healthcare Inc (NYSE:HCA) have received an average rating of “Buy” from the twenty ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and thirteen have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $147.29.

HCA has been the topic of a number of analyst reports. BMO Capital Markets cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $121.00 to $100.00 in a research report on Monday, July 13th. Mizuho boosted their price target on shares of HCA Healthcare from $136.00 to $145.00 and gave the company a “buy” rating in a research report on Thursday, July 23rd. Deutsche Bank boosted their price target on shares of HCA Healthcare from $132.00 to $150.00 in a research report on Thursday, July 23rd. Zacks Investment Research cut shares of HCA Healthcare from a “hold” rating to a “sell” rating and set a $103.00 price target on the stock. in a research report on Tuesday, June 23rd. Finally, SunTrust Banks boosted their price target on shares of HCA Healthcare from $130.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, July 23rd.

In other HCA Healthcare news, SVP P. Martin Paslick sold 254 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $132.97, for a total transaction of $33,774.38. Following the completion of the sale, the senior vice president now directly owns 5,442 shares of the company’s stock, valued at $723,622.74. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider A Bruce Moore, Jr. sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $133.73, for a total transaction of $2,005,950.00. Following the sale, the insider now directly owns 88,626 shares of the company’s stock, valued at $11,851,954.98. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,481 shares of company stock valued at $2,070,363. 1.80% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in HCA. Bessemer Group Inc. increased its stake in shares of HCA Healthcare by 57.8% in the first quarter. Bessemer Group Inc. now owns 363 shares of the company’s stock worth $33,000 after purchasing an additional 133 shares in the last quarter. Public Employees Retirement Association of Colorado boosted its position in shares of HCA Healthcare by 3.2% during the first quarter. Public Employees Retirement Association of Colorado now owns 50,903 shares of the company’s stock worth $4,574,000 after acquiring an additional 1,602 shares during the last quarter. Alps Advisors Inc. boosted its position in shares of HCA Healthcare by 3.8% during the first quarter. Alps Advisors Inc. now owns 2,904 shares of the company’s stock worth $261,000 after acquiring an additional 107 shares during the last quarter. Wetherby Asset Management Inc. boosted its position in shares of HCA Healthcare by 4.2% during the first quarter. Wetherby Asset Management Inc. now owns 5,013 shares of the company’s stock worth $450,000 after acquiring an additional 201 shares during the last quarter. Finally, Rhumbline Advisers boosted its position in shares of HCA Healthcare by 6.1% during the first quarter. Rhumbline Advisers now owns 470,532 shares of the company’s stock worth $42,277,000 after acquiring an additional 27,080 shares during the last quarter. 68.28% of the stock is owned by hedge funds and other institutional investors.

Shares of HCA stock opened at $135.80 on Friday. The company has a 50 day moving average of $132.59 and a 200-day moving average of $111.31. The company has a quick ratio of 0.95, a current ratio of 1.09 and a debt-to-equity ratio of 54.19. HCA Healthcare has a 12-month low of $58.38 and a 12-month high of $151.97. The firm has a market cap of $45.90 billion, a P/E ratio of 14.00, a PEG ratio of 1.20 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.94) by $4.17. The company had revenue of $11.07 billion during the quarter, compared to the consensus estimate of $10.44 billion. HCA Healthcare had a net margin of 6.67% and a negative return on equity of 589.47%. HCA Healthcare’s revenue for the quarter was down 12.2% on a year-over-year basis. During the same period last year, the firm earned $2.21 EPS. As a group, equities analysts expect that HCA Healthcare will post 10.12 EPS for the current year.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Pattern Day Trader

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.